Literature DB >> 20966974

Cystic macular oedema on spectral-domain optical coherence tomography in choroideremia patients without cystic changes on fundus examination.

M A Genead1, G A Fishman.   

Abstract

PURPOSE: To determine the prevalence of cystic macular oedema (CME) in patients with choroideremia (CHM) by using spectral-domain optical coherence tomography (SD-OCT).
METHODS: A total 16 patients affected with CHM were enrolled in the study. All patients underwent a complete eye examination. SD-OCT was performed using an OPKO spectral-domain OCT/SLO instrument.
RESULTS: The average age of the study patients was 44.0 ± 16.0 years (range, 13-63 years). Out of the 16 patients with CHM, 10 patients (62.5%) showed a degree of CME on SD-OCT testing in at least one eye, and 8 patients (50%) showed CME in both eyes.
CONCLUSIONS: Because of its notable prevalence, it would seem prudent to screen CHM patients by SD-OCT for the possible presence of CME and to identify those amenable to future treatment strategies for their macular oedema.

Entities:  

Mesh:

Year:  2010        PMID: 20966974      PMCID: PMC3020991          DOI: 10.1038/eye.2010.157

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  26 in total

1.  Optical coherence tomography of cystoid macular edema associated with retinitis pigmentosa.

Authors:  H Hirakawa; H Iijima; T Gohdo; S Tsukahara
Journal:  Am J Ophthalmol       Date:  1999-08       Impact factor: 5.258

2.  Detection and characterization of point mutations in the choroideremia candidate gene by PCR-SSCP analysis and direct DNA sequencing.

Authors:  J A van den Hurk; T J van de Pol; C M Molloy; F Brunsmann; K Rüther; E Zrenner; A J Pinckers; I H Pawlowitzki; E M Bleeker-Wagemakers; B Wieringa
Journal:  Am J Hum Genet       Date:  1992-06       Impact factor: 11.025

3.  Unusual macular findings in a known choroideremia carrier.

Authors:  M A Majid; B Horsborough; R H Gray
Journal:  Eye (Lond)       Date:  1998       Impact factor: 3.775

4.  Choroideremia: variability of clinical and electrophysiological characteristics and first report of a negative electroretinogram.

Authors:  Agnes B Renner; Ulrich Kellner; Elke Cropp; Markus N Preising; Ian M MacDonald; José A J M van den Hurk; Frans P M Cremers; Michael H Foerster
Journal:  Ophthalmology       Date:  2006-08-28       Impact factor: 12.079

5.  Progression of gyrate atrophy of the choroid and retina. A long-term follow-up by fluorescein angiography.

Authors:  K Vannas-Sulonen
Journal:  Acta Ophthalmol (Copenh)       Date:  1987-02

6.  Cloning of a gene that is rearranged in patients with choroideraemia.

Authors:  F P Cremers; D J van de Pol; L P van Kerkhoff; B Wieringa; H H Ropers
Journal:  Nature       Date:  1990-10-18       Impact factor: 49.962

7.  Macular edema associated with gyrate atrophy managed with intravitreal triamcinolone: a case report.

Authors:  Daniel Vítor Vasconcelos-Santos; Erika Pacheco Magalhães; Márcio Bittar Nehemy
Journal:  Arq Bras Oftalmol       Date:  2007 Sep-Oct       Impact factor: 0.872

8.  Prevalence of cystic macular lesions in patients with Usher II syndrome.

Authors:  S Walia; G A Fishman; M Hajali
Journal:  Eye (Lond)       Date:  2008-04-18       Impact factor: 3.775

9.  Clinical findings in a carrier of a new mutation in the choroideremia gene.

Authors:  Michael J Potter; Edward Wong; Shelagh M Szabo; Kerry E McTaggart
Journal:  Ophthalmology       Date:  2004-10       Impact factor: 12.079

10.  Retinal degeneration in choroideremia: deficiency of rab geranylgeranyl transferase.

Authors:  M C Seabra; M S Brown; J L Goldstein
Journal:  Science       Date:  1993-01-15       Impact factor: 47.728

View more
  19 in total

1.  Chronic cystoid macular oedema treated with intravitreal dobesilate.

Authors:  Pedro Cuevas; Luis A Outeiriño; Javier Angulo; Guillermo Giménez-Gallego
Journal:  BMJ Case Rep       Date:  2012-07-09

2.  Topical dorzolamide for treatment of cystoid macular edema in patients with choroideremia.

Authors:  Mohamed A Genead; Jason J McAnany; Gerald A Fishman
Journal:  Retina       Date:  2012-04       Impact factor: 4.256

3.  Ocular coherence tomography findings in a case of choroideremia.

Authors:  Savleen Kaur; Nishant Sachdev
Journal:  Int Ophthalmol       Date:  2013-03-29       Impact factor: 2.031

4.  High-resolution adaptive optics retinal imaging of cellular structure in choroideremia.

Authors:  Jessica I W Morgan; Grace Han; Eva Klinman; William M Maguire; Daniel C Chung; Albert M Maguire; Jean Bennett
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-09-04       Impact factor: 4.799

5.  Detection of clinical and subclinical retinal abnormalities in neurosarcoidosis with optical coherence tomography.

Authors:  Christopher Eckstein; Shiv Saidha; Elias S Sotirchos; Gita Byraiah; Michaela Seigo; Aleksandra Stankiewicz; Stephanie B Syc; E'tona Ford; Srilakshmi Sharma; Peter A Calabresi; Carlos A Pardo
Journal:  J Neurol       Date:  2012-01-04       Impact factor: 4.849

6.  Natural History of the Central Structural Abnormalities in Choroideremia: A Prospective Cross-Sectional Study.

Authors:  Tomas S Aleman; Grace Han; Leona W Serrano; Nicole M Fuerst; Emily S Charlson; Denise J Pearson; Daniel C Chung; Anastasia Traband; Wei Pan; Gui-Shuang Ying; Jean Bennett; Albert M Maguire; Jessica I W Morgan
Journal:  Ophthalmology       Date:  2016-12-13       Impact factor: 12.079

7.  CHOROIDEREMIA: Retinal Degeneration With an Unmet Need.

Authors:  Mark E Pennesi; David G Birch; Jacque L Duncan; Jean Bennett; Aniz Girach
Journal:  Retina       Date:  2019-11       Impact factor: 4.256

8.  High-resolution images of retinal structure in patients with choroideremia.

Authors:  Reema Syed; Sanna M Sundquist; Kavitha Ratnam; Shiri Zayit-Soudry; Yuhua Zhang; J Brooks Crawford; Ian M MacDonald; Pooja Godara; Jungtae Rha; Joseph Carroll; Austin Roorda; Kimberly E Stepien; Jacque L Duncan
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-02-01       Impact factor: 4.799

9.  Retinal nerve fiber thickness measurements in choroideremia patients with spectral-domain optical coherence tomography.

Authors:  Mohamed A Genead; J Jason McAnany; Gerald A Fishman
Journal:  Ophthalmic Genet       Date:  2011-01-26       Impact factor: 1.803

10.  Optical coherence tomography (OCT) features of cystoid spaces in choroideremia (CHM).

Authors:  Vittoria Murro; Dario Pasquale Mucciolo; Dario Giorgio; Andrea Sodi; Ilaria Passerini; Giacomo Bacci; Sara Bargiacchi; Gianni Virgili; Stanislao Rizzo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-10-26       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.